A citation-based method for searching scientific literature

Hirohide Sawada, Hiroshi Ishiguro, Kazuhiro Nishii, Kouji Yamada, Kunihiro Tsuchida, Hisahide Takahashi, Jun Goto, Ichiro Kanazawa, Toshiharu Nagatsu. Neurosci Res 2007
Times Cited: 12







List of co-cited articles
370 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death.
Montserrat Arrasate, Siddhartha Mitra, Erik S Schweitzer, Mark R Segal, Steven Finkbeiner. Nature 2004
50


Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.
Patrick Weydt, Victor V Pineda, Anne E Torrence, Randell T Libby, Terrence F Satterfield, Eduardo R Lazarowski, Merle L Gilbert, Gregory J Morton, Theodor K Bammler, Andrew D Strand,[...]. Cell Metab 2006
444
50

Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease.
Anthone W Dunah, Hyunkyung Jeong, April Griffin, Yong-Man Kim, David G Standaert, Steven M Hersch, M Maral Mouradian, Anne B Young, Naoko Tanese, Dimitri Krainc. Science 2002
536
41


In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets.
Weiguo Zhai, Hyunkyung Jeong, Libin Cui, Dimitri Krainc, Robert Tjian. Cell 2005
129
41

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.
J S Steffan, A Kazantsev, O Spasic-Boskovic, M Greenwald, Y Z Zhu, H Gohler, E E Wanker, G P Bates, D E Housman, L M Thompson. Proc Natl Acad Sci U S A 2000
790
41

Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease.
Melinda M Zeron, Oskar Hansson, Nansheng Chen, Cheryl L Wellington, Blair R Leavitt, Patrik Brundin, Michael R Hayden, Lynn A Raymond. Neuron 2002
453
41

Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.
Laurent R Gauthier, Bénédicte C Charrin, Maria Borrell-Pagès, Jim P Dompierre, Hélène Rangone, Fabrice P Cordelières, Jan De Mey, Marcy E MacDonald, Volkmar Lessmann, Sandrine Humbert,[...]. Cell 2004
797
41

Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.
M DiFiglia, E Sapp, K O Chase, S W Davies, G P Bates, J P Vonsattel, N Aronin. Science 1997
41

Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration.
Libin Cui, Hyunkyung Jeong, Fran Borovecki, Christopher N Parkhurst, Naoko Tanese, Dimitri Krainc. Cell 2006
759
41

p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.
Byoung-Il Bae, Hong Xu, Shuichi Igarashi, Masahiro Fujimuro, Nishant Agrawal, Yoichi Taya, S Diane Hayward, Timothy H Moran, Craig Montell, Christopher A Ross,[...]. Neuron 2005
360
41

Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.
C Zuccato, A Ciammola, D Rigamonti, B R Leavitt, D Goffredo, L Conti, M E MacDonald, R M Friedlander, V Silani, M R Hayden,[...]. Science 2001
940
33


Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
Amaal J Starling, Véronique M André, Carlos Cepeda, Marianne de Lima, Scott H Chandler, Michael S Levine. J Neurosci Res 2005
70
33

Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates.
D Martindale, A Hackam, A Wieczorek, L Ellerby, C Wellington, K McCutcheon, R Singaraja, P Kazemi-Esfarjani, R Devon, S U Kim,[...]. Nat Genet 1998
382
33

Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes.
Chiara Zuccato, Marzia Tartari, Andrea Crotti, Donato Goffredo, Marta Valenza, Luciano Conti, Tiziana Cataudella, Blair R Leavitt, Michael R Hayden, Tõnis Timmusk,[...]. Nat Genet 2003
658
33

Haloperidol protects striatal neurons from dysfunction induced by mutated huntingtin in vivo.
Delphine Charvin, Emmanuel Roze, Valérie Perrin, Carole Deyts, Sandrine Betuing, Christiane Pagès, Etienne Régulier, Ruth Luthi-Carter, Emmanuel Brouillet, Nicole Déglon,[...]. Neurobiol Dis 2008
45
33

Amyloid formation by mutant huntingtin: threshold, progressivity and recruitment of normal polyglutamine proteins.
C C Huang, P W Faber, F Persichetti, V Mittal, J P Vonsattel, M E MacDonald, J F Gusella. Somat Cell Mol Genet 1998
212
33

Transcriptional abnormalities in Huntington disease.
Katharine L Sugars, David C Rubinsztein. Trends Genet 2003
421
33

Neuroprotective effects of synaptic modulation in Huntington's disease R6/2 mice.
Edward C Stack, Alpaslan Dedeoglu, Karen M Smith, Kerry Cormier, James K Kubilus, Mikhail Bogdanov, Wayne R Matson, Lichuan Yang, Bruce G Jenkins, Ruth Luthi-Carter,[...]. J Neurosci 2007
59
33

Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription.
T Shimohata, T Nakajima, M Yamada, C Uchida, O Onodera, S Naruse, T Kimura, R Koide, K Nozaki, Y Sano,[...]. Nat Genet 2000
317
33

Interaction of Huntington disease protein with transcriptional activator Sp1.
Shi-Hua Li, Anna L Cheng, Hui Zhou, Suzanne Lam, Manjula Rao, He Li, Xiao-Jiang Li. Mol Cell Biol 2002
259
33

Widespread disruption of repressor element-1 silencing transcription factor/neuron-restrictive silencer factor occupancy at its target genes in Huntington's disease.
Chiara Zuccato, Nikolai Belyaev, Paola Conforti, Lezanne Ooi, Marzia Tartari, Evangelia Papadimou, Marcy MacDonald, Elisa Fossale, Scott Zeitlin, Noel Buckley,[...]. J Neurosci 2007
204
33

Identities of sequestered proteins in aggregates from cells with induced polyglutamine expression.
S T Suhr, M C Senut, J P Whitelegge, K F Faull, D B Cuizon, F H Gage. J Cell Biol 2001
162
33

Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity.
F C Nucifora , M Sasaki, M F Peters, H Huang, J K Cooper, M Yamada, H Takahashi, S Tsuji, J Troncoso, V L Dawson,[...]. Science 2001
820
33

Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene.
J H Cha, C M Kosinski, J A Kerner, S A Alsdorf, L Mangiarini, S W Davies, J B Penney, G P Bates, A B Young. Proc Natl Acad Sci U S A 1998
414
33


Global changes to the ubiquitin system in Huntington's disease.
Eric J Bennett, Thomas A Shaler, Ben Woodman, Kwon-Yul Ryu, Tatiana S Zaitseva, Christopher H Becker, Gillian P Bates, Howard Schulman, Ron R Kopito. Nature 2007
391
33

Dysregulation of gene expression in the R6/2 model of polyglutamine disease: parallel changes in muscle and brain.
Ruth Luthi-Carter, Sarah A Hanson, Andrew D Strand, Donald A Bergstrom, Wanjoo Chun, Nikki L Peters, Annette M Woods, Edmond Y Chan, Charles Kooperberg, Dimitri Krainc,[...]. Hum Mol Genet 2002
297
33

Dopaminergic signaling and striatal neurodegeneration in Huntington's disease.
Tie-Shan Tang, Xi Chen, Jing Liu, Ilya Bezprozvanny. J Neurosci 2007
144
33

Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins.
Prasanna Venkatraman, Ronald Wetzel, Motomasa Tanaka, Nobuyuki Nukina, Alfred L Goldberg. Mol Cell 2004
289
33

Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions.
Elizabeth J Slow, Rona K Graham, Alexander P Osmand, Rebecca S Devon, Ge Lu, Yu Deng, Jacqui Pearson, Kuljeet Vaid, Nagat Bissada, Ronald Wetzel,[...]. Proc Natl Acad Sci U S A 2005
201
33

Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.
R Luthi-Carter, A Strand, N L Peters, S M Solano, Z R Hollingsworth, A S Menon, A S Frey, B S Spektor, E B Penney, G Schilling,[...]. Hum Mol Genet 2000
566
33

Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo.
E Scherzinger, R Lurz, M Turmaine, L Mangiarini, B Hollenbach, R Hasenbank, G P Bates, S W Davies, H Lehrach, E E Wanker. Cell 1997
33

Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease.
Gary Lynch, Eniko A Kramar, Christopher S Rex, Yousheng Jia, Danielle Chappas, Christine M Gall, Danielle A Simmons. J Neurosci 2007
145
33

Altered NMDA receptor trafficking in a yeast artificial chromosome transgenic mouse model of Huntington's disease.
Mannie M Y Fan, Herman B Fernandes, Lily Y J Zhang, Michael R Hayden, Lynn A Raymond. J Neurosci 2007
89
33

Mitogen- and stress-activated protein kinase-1 deficiency is involved in expanded-huntingtin-induced transcriptional dysregulation and striatal death.
Emmanuel Roze, Sandrine Betuing, Carole Deyts, Estelle Marcon, Karen Brami-Cherrier, Christiane Pagès, Sandrine Humbert, Karine Mérienne, Jocelyne Caboche. FASEB J 2008
64
33

Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines.
Alexander V Panov, Claire-Anne Gutekunst, Blair R Leavitt, Michael R Hayden, James R Burke, Warren J Strittmatter, J Timothy Greenamyre. Nat Neurosci 2002
754
33

Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro.
Eugenia Trushina, Roy B Dyer, John D Badger, Daren Ure, Lars Eide, David D Tran, Brent T Vrieze, Valerie Legendre-Guillemin, Peter S McPherson, Bhaskar S Mandavilli,[...]. Mol Cell Biol 2004
376
33

Age-dependent and tissue-specific CAG repeat instability occurs in mouse knock-in for a mutant Huntington's disease gene.
H Ishiguro, K Yamada, H Sawada, K Nishii, N Ichino, M Sawada, Y Kurosawa, N Matsushita, K Kobayashi, J Goto,[...]. J Neurosci Res 2001
54
33

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.
L Mangiarini, K Sathasivam, M Seller, B Cozens, A Harper, C Hetherington, M Lawton, Y Trottier, H Lehrach, S W Davies,[...]. Cell 1996
33

Polyglutamine and transcription: gene expression changes shared by DRPLA and Huntington's disease mouse models reveal context-independent effects.
Ruth Luthi-Carter, Andrew D Strand, Sarah A Hanson, Charles Kooperberg, Gabriele Schilling, Albert R La Spada, Diane E Merry, Anne B Young, Christopher A Ross, David R Borchelt,[...]. Hum Mol Genet 2002
170
33

Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
S W Davies, M Turmaine, B A Cozens, M DiFiglia, A H Sharp, C A Ross, E Scherzinger, E E Wanker, L Mangiarini, G P Bates. Cell 1997
33


Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila.
Shermali Gunawardena, Lu-Shiun Her, Richard G Brusch, Robert A Laymon, Ingrid R Niesman, Beth Gordesky-Gold, Louis Sintasath, Nancy M Bonini, Lawrence S B Goldstein. Neuron 2003
476
25

Complex I defect in muscle from patients with Huntington's disease.
J Arenas, Y Campos, R Ribacoba, M A Martín, J C Rubio, P Ablanedo, A Cabello. Ann Neurol 1998
133
25

Huntingtin facilitates dynein/dynactin-mediated vesicle transport.
Juliane P Caviston, Jennifer L Ross, Sheila M Antony, Mariko Tokito, Erika L F Holzbaur. Proc Natl Acad Sci U S A 2007
203
25

Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.
Andrew D Strand, Zachary C Baquet, Aaron K Aragaki, Peter Holmans, Lichuan Yang, Carine Cleren, M Flint Beal, Lesley Jones, Charles Kooperberg, James M Olson,[...]. J Neurosci 2007
163
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.